Partnership Leverage Sterling's acquisition by Meridian Clinical Research and the resulting multi-site expansion create a sales opening to align with Meridian's network. The firm’s strengths in rapid regulatory submissions, ability to use Central IRB, fast startup, and high enrollment performance match the needs of a growing multi-site trial portfolio—ideal for cross-selling site initiation, regulatory support, and enrollment optimization across Meridian sites.

Niche Expertise Historical expertise in casinos and hospitality positions Sterling as a niche CRO for casino and hospitality research or related studies. This differentiator can be leveraged to win sector-focused work within Meridian's ecosystem or new customers seeking specialized market or clinical research capabilities in that vertical.

Operational Velocity Consistent fast timelines and enrollment success indicate Sterling can help sponsors accelerate milestones. Target opportunities include expedited start-up packages, centralized IRB support, and enrollment acceleration services for new sites or sponsors aiming to reduce cycle times.

Flexible Capacity With a lean team, Sterling offers flexible resourcing. Propose staff augmentation, dedicated program management, and modular CRO services that scale with project scope, site counts, and sponsor demands to complement Meridian's growing network.

Digital Modernization Available digital tools and web presence suggest room for tech-enabled improvements. Offer modernization of patient recruitment portals, eConsent workflows, analytics dashboards, and integration-ready data capture to improve site performance, tracking, and regulatory readiness across locations.